Skip to main content
NCBI home page
Physiological Reports logoLink to Physiological Reports
. 2022 Apr 19;10(8):e15272. doi: 10.14814/phy2.15272

The safety of exercise for older patients with severe aortic stenosis undergoing conservative management: A narrative review

Satoshi Nashimoto 1,✉, Tatsuro Inoue 2, Kazuki Hotta 2, Yuichi Sugito 1, Susumu Iida 1, Atsuhiro Tsubaki 2
PMCID: PMC9017979  PMID: 35439351

Abstract

The incidence of aortic stenosis (AS) increases with age and is a serious problem in an aging society. In recent years, transcatheter aortic valve implantation (TAVI) has been performed widely; however, older patients may be ineligible for TAVI or surgical treatment because of medical ineligibility. Symptom‐based rehabilitation is required for these patients to maintain and improve their physical function and ability to perform activities of daily living. No studies have examined exercise safety for older patients with severe AS who are ineligible for TAVI or surgery. We summarized the safety of exercise for older patients with severe AS, collecting 7 studies on maximal exercise stress tests and 16 studies on preoperative physical examinations. From this review, it may be unlikely that exercise under appropriate management can cause hemodynamic changes, leading to death. However, there were no studies on exercise intervention for older patients with AS who are chosen for conservative management. The optimal exercise intensity for symptomatic older patients with AS undergoing conservative management and the effects of continuous exercise intervention require future study.

Keywords: activities of daily living, aortic valve stenosis, conservative management, rehabilitation, symptomatic

We summarized the safety of exercise for older patients with severe AS. From this review, it may be unlikely that exercise under appropriate management can cause hemodynamic changes, leading to death. There were no studies on exercise intervention for older patients with AS who are chosen for conservative management, the optimal exercise intensity and the effects of continuous exercise intervention require future study.

graphic file with name PHY2-10-e15272-g003.jpg

1. INTRODUCTION

The incidence of aortic stenosis (AS), which increases with age, is a serious problem in an aging society (Danielsen et al., 2014; De Sciscio et al., 2017; Durko et al., 2018; Eveborn et al., 2013; Nkomo et al., 2009). In asymptomatic patients with severe AS, the risk of sudden death is low (<1%/year). However, once symptoms appear, 3% of patients may die within 6 months and 50% within 2 years (Otto et al., 1997; Pellikka et al., 2005; Rosenhek et al., 2000, 2010). Thus, managing symptomatic patients with severe AS is a critical problem because of improving life expectancy.

Management is determined by symptoms, disease severity, and surgical tolerance (De Sciscio et al., 2017; Durko et al., 2018; Otto et al., 2021; Vahanian et al., 2021). In symptomatic cases, surgical treatment or transcatheter aortic valve implantation (TAVI) is the first choice (Vahanian et al., 2021; Otto et al., 2021). In recent years, TAVI has become popular and is now indicated for some high‐risk patients (Vahanian et al., 2021; De Sciscio et al., 2017; Durko et al., 2018; Iung et al., 2005; Otto et al., 2021). The older patients who also have frailty or comorbidities such as chronic obstructive pulmonary disease, anemia, and other systemic conditions, TAVI are considered in weighing the risk–benefit ratio in an individual patient (Otto et al., 2021). Durko et al. reported that 58.4% of symptomatic patients with AS underwent surgical aortic valve replacement (SAVR), 61.7% of high‐risk patients who had difficulty with SAVR underwent TAVI, and the remaining 38.3% received medical therapy alone (Durko et al., 2018). Patients unable to undergo SAVR or TAVI require rehabilitation to maintain and improve their physical function and ability to perform activities of daily living (ADLs), checking for symptoms such as heart failure (Horstkotte & Loogen, 1998). However, the actual rehabilitation status for older patients with severe AS remains unclear.

Improving physical function and ADLs for older patients with severe AS undergoing conservative management should not be overlooked. For asymptomatic patients with mild to moderate AS, participation in recreational sports of low to moderate intensity is recommended for individuals with a left ventricular ejection fraction (LVEF) >50% and good functional capacity (Pelliccia et al., 2021). For symptomatic patients with severe AS, physical frailty is associated with increased mortality, and this association does not vary by treatment type (SAVR or TAVI) or conservative management (Rodríguez‐Pascual et al., 2016). In contrast, patients with symptomatic valvular disease are considered unstable and have activity limitations (Fletcher et al., 2013). Figure 1 summarizes the treatment, exercise, and rehabilitation of patients with AS in their severity and surgical tolerance, but the exercise and rehabilitation of these patients are constrained.

FIGURE 1.

FIGURE 1

Open in a new tab

Management of aortic valve stenosis

No studies have indicated safe rehabilitation methods for these patients. Evidence on the appropriate exercise intensity and duration to maintain and improve physical function is also lacking. Understanding what is safe for these patients can help cardiologists and physical therapists prescribe suitable exercises. In this review, we summarize the reality and safety of exercise for older patients with severe AS undergoing conservative management.

2. MATERIALS AND METHODS

We pooled clinical studies on exercise in subjects, including older patients with severe AS, extracting those in which exercise intervention was performed. We used PubMed (MEDLINE) to search for studies published between 2011 and April 2021, with the following keywords: “aortic valve stenosis,” “conservative,” “exercise,” “physical therapy,” and “rehabilitation.” To review recent studies in older patients with severe AS, we selected the studies published in English 10 years since the PARTNER trial was published in 2010 (Leon et al., 2010). The inclusion criteria for the studies considered in this review were as follows.

  • Observational and intervention studies.

  • Studies of exercise interventions in the conservative period of aortic valve stenosis.

  • Studies involving elderly patients aged 60 years or older.

To clarify the safety of exercise stress in clinically problematic symptomatic cases, we also included studies that conducted preoperative physical examinations. We excluded studies that nonhuman subjects; postoperative exercise interventions; patients aged <60 years; case reports, reviews, protocols, and incidence reports; and those published in languages other than English.

One of the authors (S.N.) reviewed the abstracts of these studies for potential inclusion in the study. In this part, preference was given to the inclusion side. If the full text of studies did not meet the inclusion criteria, the study was excluded. Finally, we identified seven studies that performed maximal exercise stress tests; in addition, we identified 16 studies that performed preoperative physical examinations. Figure 2 showed the flowchart of paper selection.

FIGURE 2.

FIGURE 2

Open in a new tab

Flowchart of the study selection

We extracted data on serious adverse events, such as death precipitated by the exercise tests, and symptoms during “exercise” angina, dyspnea, abnormal blood pressure (BP) decrease or elevation, and electrocardiogram changes (nonsustained), arrhythmias (Huded et al., 2018), ST depression by more than 2 mm during testing (Van Le et al., 2016) from the studies retrieved. Abnormal BP response was defined as decrease during testing (Huded et al., 2018), lack of systolic BP increases of at least 20 mmHg (Van Le et al., 2016), a sustained fall in systolic BP at least 20 mmHg below the previous stage or a failure to rise from the baseline level, and peak systolic BP at least 190 mmHg during testing (Saeed et al., 2019). In addition, we investigated patients’ hemodynamic changes.

3. RESULTS

In the studies on maximal exercise stress tests, one used the 6‐min walk test (Sigvardsen et al., 2017), two used treadmill tests (Huded et al., 2018; Saeed et al., 2019), two were ergometer interventions in the supine position (one also performed a treadmill test) (Christensen et al., 2016; Lumley et al., 2016), one was a cardiopulmonary exercise test in the upright position (Van Le et al., 2016), and one involved the Valsalva maneuver (Losi et al., 2015). Four included asymptomatic cases (Christensen et al., 2016; Huded et al., 2018; Saeed et al., 2019; Sigvardsen et al., 2017), two included symptomatic cases (Losi et al., 2015; Lumley et al., 2016), and one included both (Van Le et al., 2016). All studies included patients with a preserved LVEF ≥50%.

No studies reported serious adverse events, such as death or symptom worsening precipitated by the exercise stress tests. Dyspnea, arrhythmia, and dizziness during exercise occurred in 18%−67% of the patients. The rate of symptom occurrence was high with the Valsalva maneuver, and no studies reported symptoms during exercise in the supine position (Table 1). Patients with other valvular diseases (Huded et al., 2018; Saeed et al., 2019; Sigvardsen et al., 2017; Van Le et al., 2016), anemia (Saeed et al., 2019), and cases of arthritis that were difficult to perform the exercise test (Saeed et al., 2019) were excluded from each study. Patients with the chronic obstructive pulmonary disease were included in two studies (Sigvardsen et al., 2017; Van Le, 2016).

TABLE 1.

Exercise stress test for older patients with AS

Authors (year) Exercise Sublect (female/male), n Age (years) BMI (kg/m²) Asymptomatic or symptomatic Echocardiography (rest) Symptoms during exercise (n, %) Serious adverse events
AVA (cm²) or AVAI (cm²/m²) Peak velocity (m/s) Mean gradient aortic valve (mmHg) LVEF (%)
Huded et al., 2018 Treadmill test 504 (112/392) 66 ± 12 28 ± 5 Asymptomatic

AVA,079 ± 0.2

AVAI,

0.46 ± 0.1 [<0.6]

 – 58 ± 18 [>50] 58 ± 4 [>50]

General fatigue: 411 (81.5%)

Dyspnea: 42 (8.3%)

Abnormal BP response: 25 (5.0%)

Angina: 15 (3.0%)

Arrhythmia: 8 (5 NSVT) (1.6%)

Dizziness: 3 (0.6%)

 –
Van Le et al., 2016 CPX upright bicycle ergometer 131 (48/83) 72.1 ± 9.3 26.8 ± 4.0 Asymptomatic and symptomatic

AVA,

[<1.3]

AVAI,

0.45 ± 0.11

 3.92 ± 0.77 38.2 ± 15.3 [>50]

Angina, severe dizziness, discomfort, dyspnea: 25 (19.1%)

Abnormal BP response: 35 (26.7%)

ST depressions: >2 mm 12 (9.2%)

 –
Saeed et al., 2019 Treadmill test Normotensive, 85 (26/59) 58 ± 14 – Asymptomatic (Moderate−severe)

AVA,

0.94 ± 0.23

 3.7 ± 0.7 35 ± 15 61 ± 8 Abnormal BP response: 23 (27.1%) –
Hypertensive, 229 (78/151) 68 ± 10 –

AVA,

0.94 ± 0.2

 3.7 ± 0.7 34 ± 13 60 ± 6 Abnormal BP response: 69 (30.1%)
Sigvardsen et al., 2017 6MWT

Nonperformer,

9 (2/7)

 72 ± 9 31.3 ± 6.9 Asymptomatic (Mild−severe)

AVA,

1.14 ± 0.28

 3.3 ± 0.6 [>2.5] 25 ± 11 60 (57–68) [>50] – –
Short, <390 m, 37 (14/23) 75 ± 9 27.8 ± 4.0

AVA,

1.01 ± 0.24

 3.3 ± 0.6 [>2.5] 28 ± 12 59 (55–64) [>50]
Intermediate, 390−465 m, 37 (10/27) 73 ± 7 26.4 ± 4.2

AVA,

0.99 ± 0.35

 3.4 ± 0.8 [>2.5] 30 ± 18 57 (55–62) [>50]
Long, >465 m, 33 (5/28) 67 ± 8 26.0 ± 3.0

AVA,

1.01 ± 0.32

 3.57 ± 0.8 [>2.5] 33 ± 17 60 (55–67) [>50]
Christensen et al., 2016 Supine cycle ergometer exercise and treadmill test 39 (9/30) 73 ± 7 [>18] – Asymptomatic

AVA,

0.83 ± 0.17

[<1.0]

AVAI,

0.44 ± 0.09

 4.2 ± 0.5 [>3.0] 46 ± 13

66 ± 7

[>50]

 – –
Lumley et al., 2016 Supine bicycle exercise 22 (4/18) 69 ± 8 – Symptomatic 0.74 ± 0.16 [<1.0] 4.7 ± 0.66 [>4.0] 57 ± 16 59 ± 5 [>50] – –
Losi et al., 2015 Performing a Valsalva maneuver 15 (10/5) 65 ± 8 – Symptomatic

AVAI,

0.46 ± 0.1 [<0.6]

 – 43 ± 10 [>50] Dyspnea: 10 (66.6%) –
Open in a new tab

Reported as the number or mean ± SD or median (25%–75% value) [inclusion criteria].

Abbreviations: 6MWT, 6‐min walk test; AS, aortic stenosis; AVA, aortic valve area; AVAI, aortic valve area index; BMI, body mass index; BP, blood pressure; CPX, cardiopulmonary exercise test; LVEF, left ventricular ejection fraction.

The hemodynamics during exercise are shown in Table 2. Aerobic exercises increased the heart rate, systolic BP, and diastolic BP of patients in all studies. Only one study showed a trend toward no change in the LVEF and an increase in the aortic valve peak velocity max, aortic valve mean gradient, pulmonary capillary wedge pressure, and cardiac index during exercise (Christensen et al., 2016). Conversely, when left atrium dilation was apparent, especially when the E/e′ was increased, the pulmonary capillary wedge pressure was high, particularly with exercise (Christensen et al., 2016). Saeed et al. reported that lower peak systolic BP and a rapid early rise in heart rate were associated with symptom occurrence during exercise (Saeed et al., 2019). With the Valsalva maneuver, no change in BP occurred, and there was a trend toward a decreased pressure gradient and cardiac output (Losi et al., 2015). Patients who had dyspnea during the Valsalva procedure had a higher left atrium volume index and delta stroke volume index than those who did not. Many patients in these studies were on medical controls, such as beta blockers, diuretic, calcium channel blockers, angiotensin‐converting enzyme inhibitors, and AII inhibitors (Christensen et al., 2016; Huded et al., 2018; Saeed et al., 2019; Sigvardsen et al., 2017; Van Le et al., 2016).

TABLE 2.

Hemodynamics during exercise stress test for older patients with AS.

Authors (year) Exercise Subject (n) HR (beats/min) SBP (mmHg) SpO₂ (%) Echocardiography Other
Pretest Peak Pretest Peak Pretest Peak Pretest Peak Pretest Peak
Huded et al., 2018 Treadmill test 504 68 ± 13 136 ± 23 137 ± 18 165 ± 27 – – – – – –
Van Le et al., 2016 CPX upright bicycle ergometer Asymptomatic, 38 – – – – – – – – SVi, 35.0 ± 8.5 ml/m² SVi, 44.9 ± 9.3 ml/m²
Equivocal symptomatic, 92 – – – – – – – – SVi, 31.3 ± 8.7 ml/m² SVi, 38.9 ± 9.3 ml/m²
Saeed et al., 2019 Treadmill test Normotensive, 85 76 ± 13 141 ± 25 129 ± 15 158 ± 25 – – – – – –
Hypertensive, 29 77 ± 16 131 ± 24 146 ± 18 169 ± 26 – – – – – –
Sigvardsen et al., 2017 6MWT Short, <390 m, 37 66 ± 11 73 ± 11* – – 96 ± 2 97 ± 3* – – – –
Intermediate, 390−465 m, 37 64 ± 11 77 ± 13* – – 97 ± 2 97 ± 2* – – – –
Long >465 m, 33 63 ± 10 75 ± 13* – – 96 ± 2 96 ± 3* – – – –
Christensen et al., 2016 Supine cycle ergometer exercise and treadmill test LAVi <35 ml/m², 14 64 ± 11 120 ± 23 – – – –

LVEF, 63 ± 8%

Peak velocity, 4.0 ± 0.3 m/s

AV mean gradient, 40 ± 7 mmHg

LVEF, 62 ± 9%

Peak velocity, 4.5 ± 0.3 m/s

AV mean gradient, 53 ± 12 mmHg

PCWP, 9 ± 2 mmHg

CI, 2.7 ± 0.8 l/min/m²

PCWP, 27 ± 3 mmHg

CI, 6.3 ± 1.4 l/min/m²
LAVi >35 ml/m², 25 65 ± 10 115 ± 16 – – – –

LVEF, 67 ± 6%

Peak velocity, 4.4 ± 0.6 m/s

AV mean gradient, 49 ± 14 mmHg

LVEF, 67 ± 9%

Peak velocity, 4.8 ± 0.7 m/s

AV mean gradient, 61 ± 18 mmHg

PCWP, 14 ± 4 mmHg

CI, 2.9 ± 0.5 l/min/m²

PCWP, 33 ± 5 mmHg

CI, 6.6 ± 1.4 l/min/m²
Lumley et al., 2016 Supine bicycle exercise 22 75 ± 16 117 ± 25 130 ± 19 155 ± 27 – – – – – –
Losi et al., 2015 Performing a Valsalva maneuver 15 – – 133 ± 14 131 ± 14 – –

AVAi, 0.46 ± 0.1 cm²/m²

AV mean gradient, 43 ± 10 mmHg

AVAi, 0.47 ± 0.1 cm²/m²

AV mean gradient, 30 ± 9 mmHg

 SVi, 44 ± 6 ml/m² SVi, 32 ± 6 ml/m²
Open in a new tab

Reported as the mean ± SD.

Abbreviations: AS, aortic stenosis; AVAi, aortic valve area index; CI, cardiac index; CPX, cardiopulmonary exercise test; HR, heart rate; LAVi, left atrium volume index; LVEF, left ventricular ejection fraction; PCWP, pulmonary capillary wedge pressure; SBP, systolic blood pleasure; SVi, stroke volume index.

*

Immediately after the test.

Preoperative physical examinations before surgery or TAVI included the 6‐min walk test (Abdul‐Jawad Altisent et al., 2017; DeLarochellière et al., 2015; Eichler et al., 2020; Green et al., 2013; Mok et al., 2013), gait speed (walking 15 feet) (Chauhan et al., 2016; Forcillo et al., 2017; Green, Woglom, Genereux, Daneault, et al., 2012; Green, Woglom, Genereux, Maurer, et al., 2012; Hebeler et al., 2018; Kotajarvi et al., 2017; Rodríguez‐Pascual et al., 2016; Rogers et al., 2018), grip strength (Chauhan et al., 2016; Eichler et al., 2020; Forcillo et al., 2017; Green, Woglom, Genereux, Daneault, et al., 2012; Green, Woglom, Genereux, Maurer, et al., 2012; Hebeler et al., 2018; Kotajarvi et al., 2017; Rodríguez‐Pascual et al., 2016; Rogers et al., 2018), and timed up and go test (Eichler et al., 2020; Schoenenberger et al., 2013, 2018; Stortecky et al., 2012).

No studies reported serious adverse events, such as death or symptom worsening (Table 3). However, in some studies, patients had difficulty walking because of heart failure symptoms. In such cases, the patients were excluded (Abdul‐Jawad Altisent et al., 2017) or analyzed as having a zero walking speed or distance (DeLarochellière et al., 2015; Green, Woglom, Genereux, Daneault, et al., 2012; Green, Woglom, Genereux, Maurer, et al., 2012; Mok et al., 2013). In 16 studies, preoperative physical function affected postoperative life expectancy (Abdul‐Jawad Altisent et al., 2017; Chauhan et al., 2016; Forcillo et al., 2017; Green et al., 2013; Green, Woglom, Genereux, Maurer, et al., 2012; Rodríguez‐Pascual et al., 2016; Rogers et al., 2018; Schoenenberger et al., 2013, 2018; Stortecky et al., 2012), cardiovascular event occurrence (Stortecky et al., 2012), preoperative ADLs dependence (Green, Woglom, Genereux, Daneault, et al., 2012), and postoperative functional decline (Schoenenberger et al., 2013).

TABLE 3.

Preoperative physical examinations for older patients with AS

Authors (year) Subject (female/male), n Age (years) BMI (kg/m²) Evaluation period Echocardiography (rest) Physical function assessment

Serious adverse

events
LVEF (% or n) Mean gradient aortic valve (mmHg) AVA (cm²) 6MWT Gait speed Grip strength TUG
Abdul‐Jawad et al., 2017 305 (166/139) 79 ± 9 26.5 ± 4.9 Before TAVI 53.2 ± 14.1 40.7 ± 16.8 – 〇 –
DeLarochellière et al., 2015 438 (224/214) 79 ± 8 27 ± 5 Before TAVI <40%, 72 41 ± 16 0.64 (0.50–0.80) 〇 –
Eichler et al., 2020 249 (147/102) 80.7 ± 5.1 28.0 ± 4.8 Before TAVI 54.5 ± 10.9 44.9 ± 16.5 – 〇 〇 〇 –
Green et al., 2013 Unable to walk, 218 (120/98) 84.6 (79.1–88.9) 26.2 (22.7–30.4) Before TAVI 55.4 (44.4–61.7) 41.9 (32.5–53.3) 0.63 (0.51–0.76) 〇 –
Slow walkers, 133 (60/73) 85.9 (81.7–88.5) 26.0 (22.1–30.2) 53.0 (37.6–61.3) 40.4 (33.0–51.2) 0.63 (0.53–0.73)
Fast walkers, 133 (44/89) 83.6 (78.3–87.6) 25.5 (22.8–29.0) 57.5 (48.5–64.4) 41.3 (33.3–49.2) 0.66 (0.56–0.79)
Mok et al., 2013 319 (172/147) 80 ± 8 26.8 ± 5.4 Before TAVI 54 ± 14 40 ± 16 – 〇 –
Rodríguez‐Pascual et al., 2016 Frail, 299 (191/108) 84.0 ± 4.99 – Before TAVI, SAVR, or medical treatment >45%, 79.2% 47.8 ± 15.2 – 〇 〇 –
Non‐frail, 307 (159/148) 81.9 ± 4.3 – >45%, 87.9% 49.1 ± 15.0 –
Chauhan et al., 2016 342 (179/163) 81.85 ± 7.49 28.37 ± 6.9 Before TAVI 53.23 ± 14.65 49.94 ± 16.67 – 〇 〇 –
Forcillo et al., 2017 361 (167/194) 82 (76–86) 26.5 (22.7–30.4) Before TAVI 55 (43–60) – – 〇 〇 –
Green, Woglom, Genereux, Maurer, et al., 2012 102 (53/49) 85.9 ± 8.1 24.7 ± 5.6 Before TAVI 50 ± 16 <45%, 28 [>40] [<0.8] 〇 〇 –
Green, Woglom, Genereux, Daneault, et al., 2012 159 (80/79) 86.2 ± 7.7 24.7 ± 5.6 Before TAVI 48 ± 16 45 ± 15 0.6 ± 0.2 〇 〇 –
Hebeler et al., 2018 468 (220/248) 81.7 ± 7.9 27.5 ± 6.2 Before TAVI 54.2 ± 12.8 – – 〇 〇 –
Kotajarvi et al., 2017 103 (42/61) 80.6 ± 7.4 30.5 ± 6.5 Before TAVI or SAVR 58.3 ± 12.8 49.0 ± 10.6 0.8 ± 0.2 〇 〇 –
Rogers et al., 2018 544 (277/267) 81 ± 8.4 29 ± 9 Before TAVI – – – 〇 〇 –
Schoenenberger et al., 2013 119 (66/53) 83.4 ± 4.6 26.0 ± 4.7 Before TAVI 50.8 ± 14.2 43.1 ± 15.5 0.6 ± 0.2 〇 –
Schoenenberger et al., 2018 330 (186/144) 83.6 (80.9–86.7) 25.2 (23.0–28.1) Before TAVI <35%, 39 41.0 (30.0–52.0) 0.60 (0.50–0.80) 〇 –
Stortecky et al., 2012 100 (60/40) 83.7 ± 4.6 25.6 ± 4.6 Before TAVI 50.5 ± 14.1 43.0 ± 15.9 0.6 ± 0.2 〇 –
Open in a new tab

Reported as the number or mean ± SD or median (25%–75% value) [inclusion criteria].

Abbreviations: 6MWT, 6‐min walk test; AS, aortic stenosis; AVA, aortic valve area; BMI, body mass index; LVEF, left ventricular ejection fraction; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation; TUG, timed up and go test.

4. DISCUSSION

Retrospective studies on the prognosis of severe AS have reported that the most common cardiac‐related deaths are exacerbation of heart failure (25.0%−31.3%) and sudden death (3.9%−13.0%) (Ben‐Dor et al., 2010; Minamino‐Muta et al., 2017; Toyofuku et al., 2017), whereas the relationship between death and exercise stress has not been investigated. From this review, it may be unlikely that exercise under appropriate management can cause hemodynamic changes, leading to death. However, there were no studies on exercise intervention for older patients with AS who are chosen for conservative management. We would like to suggest the possibility of exercise intervention for older conservative patients with AS, by reviewing seven studies in which maximal exercise testing was performed on asymptomatic AS patients and 16 studies in which preoperative evaluations were performed.

4.1. Safety of maximal exercise stress tests and physical examinations for older patients with as undergoing conservative management

In this review, most of the studies on maximal exercise stress tests were reported in patients with preserved LVEF and in asymptomatic patients. For asymptomatic patients, exercise testing is recommended to test whether a patient really has symptoms on effort or not (Vahanian et al., 2021; Otto et al., 2021; Saeed et al., 2018). The hemodynamics and symptom occurrence during maximal exercise in patients with reduced LVEF, symptomatic patients, and patients with other complications are unclear. However, there have been no studies of exercise stress and intervention in older patients with symptomatic severe AS undergoing conservative management. Two‐thirds of asymptomatic severe AS patients progress to a symptomatic status within the first 2 years of early follow‐up (1–24 months) (Heuvelman et al., 2012). Thus, we consider the results of this review may suggest, although limited, some precautions for exercise in older patients with symptomatic severe AS undergoing conservative management.

During maximal exercise stress tests, appropriate monitoring should be performed. In studies examining this issue, shortness of breath (Huded et al., 2018; Losi et al., 2015; Van Le et al., 2016), hypotension (Huded et al., 2018; Saeed et al., 2019; Van Le et al., 2016), and chest pain (Huded et al., 2018; Van Le et al., 2016) occurred in up to 60% of patients. Recent international prospective randomized controlled trial, although there were no serious adverse events associated with the maximal exercise stress test, some symptoms have been reported (Banovic et al., 2021). Saeed et al. reported that a rapid early rise in heart rate and a lower peak systolic BP were associated with symptom onset (Chambers et al., 2019; Saeed et al., 2019), suggesting a fall in the cardiac output in early exercise and a subsequent failure to rise. Losi et al. reported a greater left atrial volume at rest and a greater reduction in cardiac output associated with the procedure in patients who experienced shortness of breath compared with those who did not during the Valsalva maneuver, suggesting that reduced diastolic function can reduce the cardiac output during preload reduction actions (Losi et al., 2015). Christensen et al. reported that patients with diastolic dysfunction at rest had higher pulmonary venous pressure (>30 mmHg) during ergometer drive in the supine position (Christensen et al., 2016), which can lead to pulmonary congestion and is associated with shortness of breath (Buller & Poole‐Wilson, 1990). Thus, it is important to monitor BP during exercise and to check resting echocardiographic findings (left atrial volume and diastolic function) when performing exercise interventions.

Hemodynamic changes can occur depending on the exercise modality. Aerobic exercises, such as walking and ergometer, can result in an increased cardiac output (Christensen et al., 2016; Van Le et al., 2016), whereas static exercise using the Valsalva maneuver can result in a decreased output (Losi et al., 2015). These results are similar to those reported in healthy participants (Astrand et al., 1964; Delaney et al., 2020). Hemodynamic changes are different among aerobic exercises, such as walking or muscle strengthening, which can cause shortness of breath. Therefore, appropriate risk monitoring is needed.

Posture may be related to the occurrence of symptoms during exercise. Shortness of breath, hypotension, and chest pain during exercise have been reported in exercises performed in the upright position (e.g., treadmill walking, cardiopulmonary exercise test). Two studies reported no symptoms with exercises performed in the supine position (Christensen et al., 2016; Lumley et al., 2016). Thus, exercises performed in the supine position may reduce the risk of syncope and falls associated with AS and may be a safer method. Further studies on this topic are needed.

During preoperative physical examinations, no studies have reported serious accidents precipitated. Most patients were waiting for TAVI, aged, on average, in their 80s, and some had a reduced LVEF. Several of the 16 studies reported that preoperative physical function affected postoperative outcomes. However, in patients with symptoms such as heart failure, a physical examination such as walking was not performed. When performing physical examinations and exercise intervention for symptomatic patients with AS, it is necessary to manage the underlying disease and medical condition as a prerequisite.

4.2. Call for action

Physical therapy is necessary to maintain and improve physical function and to maintain the ability to perform ADLs in older patients with severe AS who are ineligible for surgery or TAVI. However, little evidence exists for exercise or rehabilitation in older patients with severe AS. There is a need to clarify the safety and effects of physical therapy on physical function and ADLs in patients with severe AS in future studies.

The perspective of palliative care cannot be excluded in older patients with severe AS undergoing conservative management (Horstkotte & Loogen, 1998). Goodlin recommended that exercise therapy be continued until the end of life to alleviate fatigue and shortness of breath (Goodlin, 2009). In addition, exercise can reduce anxiety and depression (Silveira et al., 2013), improving quality of life (Zhang et al., 2016). It is necessary to consider how to provide better exercise and end‐of‐life care to these patients while also considering their safety.

4.3. Limitation

This review has several limitations. First, we found no reports of continuous exercise interventions in older patients with symptomatic severe AS undergoing conservative management, and exercise intensity and duration to maintain or improve physical function or to acquire the ability to perform ADLs are unknown. Second, the patients in this study were aged 50−80 years, but in clinical settings, health professionals may encounter even older patients. Patients eligible for conservative management may have lower cardiac and physical functions compared with those awaiting surgery or TAVI. Therefore, pilot studies need to examine this population. Safety should be reported based on the definitions of serious adverse event and adverse event (European Medicines Agency, 2016; Ioannidis et al., 2004). Finally, selection and publication bias must be considered.

5. CONCLUSIONS

There were no studies on exercise intervention for older patients with AS who are chosen for conservative management. A review of 7 studies in which maximal exercise testing was performed on asymptomatic AS patients and 16 studies in which preoperative evaluations were performed suggests the possibility of providing exercise interventions for symptomatic older patients with severe AS under appropriate management. It is seemingly important to consider exercise for these patients who are in the terminal stages of heart failure to maintain their ADLs and to provide high‐quality end‐of‐life care, and studies of exercise interventions for these patients are needed.

CONFLICTS OF INTEREST

None.

AUTHOR CONTRIBUTION

Satoshi Nashimoto: The primary author oversaw writing the main parts of the manuscript. Satoshi Nashimoto, Tatsuro Inoue, Kazuki Hotta, Yuichi Sugito, and Susumu Iida designed the research question. Satoshi Nashimoto, Tatsuro Inoue data collection, analyzed the data. Satoshi Nashimoto, Tatsuro Inoue, Kazuki Hotta, Atsuhiro Tsubaki contributed to critical review of draft manuscripts. All authors have read and approved the final manuscript.

Nashimoto, S. , Inoue, T. , Hotta, K. , Sugito, Y. , Iida, S. , & Tsubaki, A. (2022). The safety of exercise for older patients with severe aortic stenosis undergoing conservative management: A narrative review. Physiological Reports, 10, e15272. 10.14814/phy2.15272

Funding information

This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors.

REFERENCES

  1. Abdul‐Jawad, A. O. , Puri, R. , Regueiro, A. , Chamandi, C. , Rodriguez‐Gabella, T. , Del Trigo, M. , Campelo‐Parada, F. , Couture, T. , Marsal, J. R. , Côté, M. , Paradis, J. M. , DeLarochellière, R. , Doyle, D. , Mohammadi, S. , Dumont, E. , & Rodés‐Cabau, J. (2017). Predictors and association with clinical outcomes of the changes in exercise capacity after transcatheter aortic valve replacement. Circulation, 136(7), 632–643. 10.1161/CIRCULATIONAHA.116.026349 [DOI] [PubMed] [Google Scholar]
  2. Astrand, P. O. , Cuddy, T. E. , Saltin, B. , & Stenberg, J. (1964). Cardiac output during submaximal and maximal work. Journal of Applied Physiology, 19, 268–274. 10.1152/jappl.1964.19.2.268 [DOI] [PubMed] [Google Scholar]
  3. Banovic, M. , Putnik, S. , Penicka, M. , Doros, G. , Deja, M. A. , Kockova, R. , Kotrc, M. , Glaveckaite, S. , Gasparovic, H. , Pavlovic, N. , Velicki, L. , Salizzoni, S. , Wojakowski, W. , Van Camp, G. , Nikolic, S. D. , Iung, B. , & Bartunek, J. (2022). Aortic Valve Replacement versus conservative treatment in asymptomatic severe aortic stenosis: The AVATAR trial. Circulation, 145(9), 648–658. 10.1161/CIRCULATIONAHA.121.057639 [DOI] [PubMed] [Google Scholar]
  4. Ben‐Dor, I. , Pichard, A. D. , Gonzalez, M. A. , Weissman, G. , Li, Y. , Goldstein, S. A. , Okubagzi, P. , Syed, A. I. , Maluenda, G. , Collins, S. D. , Delhaye, C. , Wakabayashi, K. , Gaglia, M. A. , Torguson, R. , Xue, Z. , Satler, L. F. , Suddath, W. O. , Kent, K. M. , Lindsay, J. , & Waksman, R. (2010). Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation, 122(11_suppl_1), 37–42. 10.1161/CIRCULATIONAHA.109.926873 [DOI] [PubMed] [Google Scholar]
  5. Buller, N. P. , & Poole‐Wilson, P. A. (1990). Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. British Heart Journal, 63(5), 281–283. 10.1136/hrt.63.5.281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chambers, J. B. , Rajani, R. , Parkin, D. , & Saeed, S. (2019). Rapid early rise in heart rate on treadmill exercise in patients with asymptomatic moderate or severe aortic stenosis: a new prognostic marker? Open Heart, 6(1), e000950. 10.1136/openhrt-2018-000950 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chauhan, D. , Haik, N. , Merlo, A. , Haik, B. J. , Chen, C. , Cohen, M. , Mosenthal, A. , & Russo, M. (2016). Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement. American Heart Journal, 182, 146–154. 10.1016/j.ahj.2016.06.028 [DOI] [PubMed] [Google Scholar]
  8. Christensen, N. L. , Dahl, J. S. , Carter‐Storch, R. , Bakkestrøm, R. , Jensen, K. , Steffensen, F. H. , Søndergaard, E. V. , Videbæk, L. , & Møller, J. E. (2016). Association between left atrial dilatation and invasive hemodynamics at rest and during exercise in asymptomatic aortic stenosis. Circulation: Cardiovascular Imaging, 9(10), e005156. 10.1161/CIRCIMAGING.116.005156 [DOI] [PubMed] [Google Scholar]
  9. Danielsen, R. , Aspelund, T. , Harris, T. B. , & Gudnason, V. (2014). The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: The AGES‐Reykjavík study. International Journal of Cardiology, 176(3), 916–922. 10.1016/j.ijcard.2014.08.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. De Sciscio, P. , Brubert, J. , De Sciscio, M. , Serrani, M. , Stasiak, J. , & Moggridge, G. D. (2017). Quantifying the shift toward transcatheter aortic valve replacement in low‐risk patients: A meta‐analysis. Circulation: Cardiovascular Quality and Outcomes, 10(6), e003287. 10.1161/CIRCOUTCOMES.116.003287 [DOI] [PubMed] [Google Scholar]
  11. Delaney, L. J. , Bellomo, R. , & van Haren, F. (2020). Responsiveness of noninvasive continuous cardiac output monitoring during the valsalva maneuver. Clinical Nursing Research, 29(2), 127–132. 10.1177/1054773818762878 [DOI] [PubMed] [Google Scholar]
  12. DeLarochellière, H. , Urena, M. , Amat‐Santos, I. J. , Ribeiro, H. B. , Allende, R. , Laflamme, L. , Laflamme, J. , Paradis, J. M. , Dumont, E. , Doyle, D. , Mohammadi, S. , DeLarochellière, R. , Côté, M. , Laroche, V. , & Rodés‐Cabau, J. (2015). Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement. American Journal of Cardiology, 115(4), 472–479. 10.1016/j.amjcard.2014.11.033 [DOI] [PubMed] [Google Scholar]
  13. Durko, A. P. , Osnabrugge, R. L. , Van Mieghem, N. M. , Milojevic, M. , Mylotte, D. , Nkomo, V. T. , & Pieter Kappetein, A. (2018). Annual number of candidates for transcatheter aortic valve implantation per country: Current estimates and future projections. European Heart Journal, 39(28), 2635–2642. 10.1093/eurheartj/ehy107 [DOI] [PubMed] [Google Scholar]
  14. Eichler, S. , Völler, H. , Reibis, R. , Wegscheider, K. , Butter, C. , Harnath, A. , & Salzwedel, A. (2020). Geriatric or cardiac rehabilitation? Predictors of treatment pathways in advanced age patients after transcatheter aortic valve implantation. BMC Cardiovascular Disorders, 20(1), 158. 10.1186/s12872-020-01452-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. European Medicines Agency . (2016). ICH E6 (R2) good clinical practice. Accessed November 23, 2021. https://www.ema.europa.eu/en/ich‐e6‐r2‐good‐clinical‐practice#currentversion‐revision‐2‐section
  16. Eveborn, G. W. , Schirmer, H. , Heggelund, G. , Lunde, P. , & Rasmussen, K. (2013). The evolving epidemiology of valvular aortic stenosis. The Tromsø Study. Heart, 99(6), 396–400. 10.1136/heartjnl-2012-302265 [DOI] [PubMed] [Google Scholar]
  17. Fletcher, G. F. , Ades, P. A. , Kligfield, P. , Arena, R. , Balady, G. J. , Bittner, V. A. , Coke, L. A. , Fleg, J. L. , Forman, D. E. , Gerber, T. C. , Gulati, M. , Madan, K. , Rhodes, J. , Thompson, P. D. , & Williams, M. A. (2013). Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation, 128(8), 873–934. 10.1161/CIR.0b013e31829b5b44 [DOI] [PubMed] [Google Scholar]
  18. Forcillo, J. , Condado, J. F. , Ko, Y. A. , Yuan, M. , Binongo, J. N. , Ndubisi, N. M. , Kelly, J. J. , Babaliaros, V. , Guyton, R. A. , Devireddy, C. , Leshnower, B. G. , Stewart, J. P. , Perrault, L. P. , Khairy, P. , & Thourani, V. H. (2017). Assessment of commonly used frailty markers for high‐ and extreme‐ risk patients undergoing transcatheter aortic valve replacement. Annals of Thoracic Surgery, 104(6), 1939–1946. 10.1016/j.athoracsur.2017.05.067 [DOI] [PubMed] [Google Scholar]
  19. Goodlin, S. J. (2009). Palliative care in congestive heart failure. Journal of the American College of Cardiology, 54(5), 386–396. 10.1016/j.jacc.2009.02.078 [DOI] [PubMed] [Google Scholar]
  20. Green, P. , Cohen, D. J. , Généreux, P. , McAndrew, T. , Arnold, S. V. , Alu, M. , Beohar, N. , Rihal, C. S. , Mack, M. J. , Kapadia, S. , Dvir, D. , Maurer, M. S. , Williams, M. R. , Kodali, S. , Leon, M. B. , & Kirtane, A. J. (2013). Relation between six‐minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). American Journal of Cardiology, 112(5), 700–706. 10.1016/j.amjcard.2013.04.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Green, P. , Woglom, A. E. , Genereux, P. , Daneault, B. , Paradis, J. M. , Schnell, S. , Hawkey, M. , Maurer, M. S. , Kirtane, A. J. , Kodali, S. , Moses, J. W. , Leon, M. B. , Smith, C. R. , & Williams, M. (2012). The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single‐center experience. JACC: Cardiovascular Interventions, 5(9), 974–981. 10.1016/j.jcin.2012.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Green, P. , Woglom, A. E. , Genereux, P. , Maurer, M. S. , Kirtane, A. J. , Hawkey, M. , Schnell, S. , Sohn, J. , Moses, J. W. , Leon, M. B. , Smith, C. R. , Williams, M. , & Kodali, S. (2012). Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clinical Cardiology, 35(5), 307–314. 10.1002/clc.21974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hebeler, K. R. , Baumgarten, H. , Squiers, J. J. , Wooley, J. , Pollock, B. D. , Mahoney, C. , Filardo, G. , Lima, B. , & DiMaio, J. M. (2018). Albumin is predictive of 1‐year mortality after transcatheter aortic valve replacement. Annals of Thoracic Surgery, 106(5), 1302–1307. 10.1016/j.athoracsur.2018.06.024 [DOI] [PubMed] [Google Scholar]
  24. Heuvelman, H. J. , van Geldorp, M. W. , Kappetein, A. P. , Geleijnse, M. L. , Galema, T. W. , Bogers, A. J. , & Takkenberg, J. J. (2012). Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: Insights from the AVARIJN study. Netherlands Heart Journal, 20(12), 487–493. 10.1007/s12471-012-0309-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Horstkotte, D. , & Loogen, F. (1988). The natural history of aortic valve stenosis. European Heart Journal, 9(suppl E), 57–64. 10.1093/eurheartj/9.suppl_E.57 [DOI] [PubMed] [Google Scholar]
  26. Huded, C. P. , Masri, A. , Kusunose, K. , Goodman, A. L. , Grimm, R. A. , Gillinov, A. M. , Johnston, D. R. , Rodriguez, L. L. , Popovic, Z. B. , Svensson, L. G. , Griffin, B. P. , & Desai, M. Y. (2018). Outcomes in asymptomatic severe aortic stenosis with preserved ejection fraction undergoing rest and treadmill stress echocardiography. Journal of the American Heart Association, 7(8), e007880. 10.1161/JAHA.117.007880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ioannidis, J. P. , Evans, S. J. , Gøtzsche, P. C. , O'Neill, R. T. , Altman, D. G. , Schulz, K. , & Moher, D. (2004). Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine, 141, 781–788. 10.7326/0003-4819-141-10-200411160-00009 [DOI] [PubMed] [Google Scholar]
  28. Iung, B. , Cachier, A. , Baron, G. , Messika‐Zeitoun, D. , Delahaye, F. , Tornos, P. , Gohlke‐Bärwolf, C. , Boersma, E. , Ravaud, P. , & Vahanian, A. (2005). Decision‐making in elderly patients with severe aortic stenosis: Why are so many denied surgery? European Heart Journal, 26(24), 2714–2720. 10.1093/eurheartj/ehi471 [DOI] [PubMed] [Google Scholar]
  29. Kotajarvi, B. R. , Schafer, M. J. , Atkinson, E. J. , Traynor, M. M. , Bruce, C. J. , Greason, K. L. , Suri, R. M. , Miller, J. D. , & LeBrasseur, N. K. (2017). The impact of frailty on patient‐centered outcomes following aortic valve replacement. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 72(7), 917–921. 10.1093/gerona/glx038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Leon, M. B. , Smith, C. R. , Mack, M. , Miller, D. C. , Moses, J. W. , Svensson, L. G. , Tuzcu, E. M. , Webb, J. G. , Fontana, G. P. , Makkar, R. R. , Brown, D. L. , Block, P. C. , Guyton, R. A. , Pichard, A. D. , Bavaria, J. E. , Herrmann, H. C. , Douglas, P. S. , Petersen, J. L. , Akin, J. J. , … Pocock, S. (2010). Transcatheter aortic‐valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine, 363(17), 1597–1607. https://www.nejm.org/doi/ [DOI] [PubMed] [Google Scholar]
  31. Losi, M. A. , Izzo, R. , Stabile, E. , Sannino, A. , Canciello, G. , Giamundo, A. , Musella, F. , Cirillo, P. , Prastaro, M. , Galderisi, M. , Trimarco, B. , & Esposito, G. (2015). Diastolic dysfunction reduces stroke volume during daily’s life activities in patients with severe aortic stenosis. International Journal of Cardiology, 195, 64–65. 10.1016/j.ijcard.2015.05.120 [DOI] [PubMed] [Google Scholar]
  32. Lumley, M. , Williams, R. , Asrress, K. N. , Arri, S. , Briceno, N. , Ellis, H. , Rajani, R. , Siebes, M. , Piek, J. J. , Clapp, B. , Redwood, S. R. , Marber, M. S. , Chambers, J. B. , & Perera, D. (2016). Coronary physiology during exercise and vasodilation in the healthy heart and in severe aortic stenosis. Journal of the American College of Cardiology, 68(7), 688–697. 10.1016/j.jacc.2016.05.071 [DOI] [PubMed] [Google Scholar]
  33. Minamino‐Muta, E. , Kato, T. , Morimoto, T. , Taniguchi, T. , Shiomi, H. , Nakatsuma, K. , Shirai, S. , Ando, K. , Kanamori, N. , Murata, K. , Kitai, T. , Kawase, Y. , Miyake, M. , Izumi, C. , Mitsuoka, H. , Kato, M. , Hirano, Y. , Matsuda, S. , Nagao, K. , … Kimura, T. (2017). Causes of death in patients with severe aortic stenosis: an observational study. Scientific Reports, 7(1), 14723. 10.1038/s41598-017-15316-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mok, M. , Nombela‐Franco, L. , Dumont, E. , Urena, M. , DeLarochellière, R. , Doyle, D. , Villeneuve, J. , Côté, M. , Ribeiro, H. B. , Allende, R. , Laflamme, J. , DeLarochellière, H. , Laflamme, L. , Amat‐Santos, I. , Pibarot, P. , Maltais, F. , & Rodés‐Cabau, J. (2013). Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. JACC: Cardiovascular Interventions, 6(10), 1072–1084. 10.1016/j.jcin.2013.06.008 [DOI] [PubMed] [Google Scholar]
  35. Nkomo, V. T. , Gardin, J. M. , Skelton, T. N. , Gottdiener, J. S. , Scott, C. G. , & Enriquez‐Sarano, M. (2009). Burden of valvular heart diseases: a population‐based study. Lancet, 368(9540), 1005–1011. 10.1016/S0140-6736(06)69208-8, [DOI] [PubMed] [Google Scholar]
  36. Otto, C. M. , Burwash, I. G. , Legget, M. E. , Munt, B. I. , Fujioka, M. , Healy, N. L. , Kraft, C. D. , Miyake‐Hull, C. Y. , & Schwaegler, R. G. (1997). Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation, 95(9), 2262–2270. 10.1161/01.CIR.95.9.2262 [DOI] [PubMed] [Google Scholar]
  37. Otto, C. M. , Nishimura, R. A. , Bonow, R. O. , Carabello, B. A. , Erwin, J. P. 3rd , Gentile, F. , Jneid, H. , Krieger, E. V. , Mack, M. , McLeod, C. , O'Gara, P. T. , Rigolin, V. H. , Sundt, T. M. 3rd , Thompson, A. , Toly, C. , O'Gara, P. T. , Beckman, J. A. , Levine, G. N. , Al‐Khatib, S. M. , … Woo, Y. J. (2021). 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation, 143, e72–e227. 10.1161/CIR.0000000000000923 [DOI] [PubMed] [Google Scholar]
  38. Pelliccia, A. , Sharma, S. , Gati, S. , Bäck, M. , Börjesson, M. , Caselli, S. , Collet, J.‐P. , Corrado, D. , Drezner, J. A. , Halle, M. , Hansen, D. , Heidbuchel, H. , Myers, J. , Niebauer, J. , Papadakis, M. , Piepoli, M. F. , Prescott, E. , Roos‐Hesselink, J. W. , Stuart, A. G. , … Wilhelm, M. (2021). 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. European Heart Journal, 42(1), 17–96. 10.1016/j.rec.2021.05.003 [DOI] [PubMed] [Google Scholar]
  39. Pellikka, P. A. , Sarano, M. E. , Nishimura, R. A. , Malouf, J. F. , Bailey, K. R. , Scott, C. G. , Barnes, M. E. , & Tajik, A. J. (2005). Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow‐up. Circulation, 111(24), 3290–3295. 10.1161/CIRCULATIONAHA.104.495903 [DOI] [PubMed] [Google Scholar]
  40. Rodríguez‐Pascual, C. , Paredes‐Galán, E. , Ferrero‐Martínez, A. I. , Baz‐Alonso, J. A. , Durán‐Muñoz, D. , González‐Babarro, E. , Sanmartín, M. , Parajes, T. , Torres‐Torres, I. , Piñón‐Esteban, M. , Calvo‐Iglesias, F. , Olcoz‐Chiva, M. T. , & Rodríguez‐Artalejo, F. (2016). The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments. International Journal of Cardiology, 224, 125–131. 10.1016/j.ijcard.2016.09.020 [DOI] [PubMed] [Google Scholar]
  41. Rogers, T. , Alraies, M. C. , Moussa Pacha, H. , Bond, E. , Buchanan, K. D. , Steinvil, A. , Gai, J. , Torguson, R. , Ben‐Dor, I. , Satler, L. F. , & Waksman, R. (2018). Clinical frailty as an outcome predictor after transcatheter aortic valve implantation. American Journal of Cardiology, 121(7), 850–855. 10.1016/j.amjcard.2017.12.035 [DOI] [PubMed] [Google Scholar]
  42. Rosenhek, R. , Binder, T. , Porenta, G. , Lang, I. , Christ, G. , Schemper, M. , Maurer, G. , & Baumgartner, H. (2000). Predictors of outcome in severe, asymptomatic aortic stenosis. New England Journal of Medicine, 343(9), 611–617. 10.1056/NEJM200008313430903 [DOI] [PubMed] [Google Scholar]
  43. Rosenhek, R. , Zilberszac, R. , Schemper, M. , Czerny, M. , Mundigler, G. , Graf, S. , Bergler‐Klein, J. , Grimm, M. , Gabriel, H. , & Maurer, G. (2010). Natural history of very severe aortic stenosis. Circulation, 121(1), 151–156. 10.1161/CIRCULATIONAHA.109.894170 [DOI] [PubMed] [Google Scholar]
  44. Saeed, S. , Mancia, G. , Rajani, R. , Parkin, D. , & Chambers, J. B. (2019). Hypertension in aortic stenosis: Relationship with revealed symptoms and functional measures on treadmill exercise. Journal of Hypertension, 37(11), 2209–2215. 10.1097/HJH.0000000000002149 [DOI] [PubMed] [Google Scholar]
  45. Saeed, S. , Rajani, R. , Seifert, R. , Parkin, D. , & Chambers, J. B. (2018). Exercise testing in patients with asymptomatic moderate or severe aortic stenosis. Heart, 104(22), 1836–1842. 10.1136/heartjnl-2018-312939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schoenenberger, A. W. , Moser, A. , Bertschi, D. , Wenaweser, P. , Windecker, S. , Carrel, T. , Stuck, A. E. , & Stortecky, S. (2018). Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC: Cardiovascular Interventions, 11(4), 395–403. 10.1016/j.jcin.2017.11.012 [DOI] [PubMed] [Google Scholar]
  47. Schoenenberger, A. W. , Stortecky, S. , Neumann, S. , Moser, A. , Jüni, P. , Carrel, T. , Huber, C. , Gandon, M. , Bischoff, S. , Schoenenberger, C. M. , Stuck, A. E. , Windecker, S. , & Wenaweser, P. (2013). Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). European Heart Journal, 34(9), 684–692. 10.1093/eurheartj/ehs304 [DOI] [PubMed] [Google Scholar]
  48. Sigvardsen, P. E. , Larsen, L. H. , Carstensen, H. G. , Kühl, J. T. , Møgelvang, R. , Hassager, C. , Køber, L. , & Kofoed, K. F. (2017). Six‐minute walking test and long term prognosis in patients with asymptomatic aortic valve stenosis. International Journal of Cardiology, 249, 334–339. 10.1016/j.ijcard.2017.09.183 [DOI] [PubMed] [Google Scholar]
  49. Silveira, H. , Moraes, H. , Oliveira, N. , Coutinho, E. S. , Laks, J. , & Deslandes, A. (2013). Physical exercise and clinically depressed patients: a systematic review and meta‐analysis. Neuropsychobiology, 67(2), 61–68. 10.1159/000345160 [DOI] [PubMed] [Google Scholar]
  50. Stortecky, S. , Schoenenberger, A. W. , Moser, A. , Kalesan, B. , Jüni, P. , Carrel, T. , Bischoff, S. , Schoenenberger, C. M. , Stuck, A. E. , Windecker, S. , & Wenaweser, P. (2012). Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC: Cardiovascular Interventions, 5(5), 489–496. 10.1016/j.jcin.2012.02.012 [DOI] [PubMed] [Google Scholar]
  51. Toyofuku, M. , Taniguchi, T. , Morimoto, T. , Yamaji, K. , Furukawa, Y. , Takahashi, K. , Tamura, T. , Shiomi, H. , Ando, K. , Kanamori, N. , Murata, K. , Kitai, T. , Kawase, Y. , Izumi, C. , Miyake, M. , Mitsuoka, H. , Kato, M. , Hirano, Y. , Matsuda, S. , … Kimura, T. (2017). Sex differences in severe aortic stenosis ‐ clinical presentation and mortality. Circulation Journal, 81(8), 1213–1221. 10.1253/circj.CJ-16-1244 [DOI] [PubMed] [Google Scholar]
  52. Vahanian, A. , Beyersdorf, F. , Milojevic, M. , Praz, F. , Baldus, S. , Bauersachs, J. , Capodanno, D. , Conradi, L. , De Bonis, M. , De Paulis, R. , Delgado, V. , Freemantle, N. , Gilard, M. , Haugaa, K. H. , Jeppsson, A. , Jüni, P. , Pierard, L. , Prendergast, B. D. , Sádaba, J. R. , … Wojakowski, W. (2021). 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 60(4), 727–800 10.1093/ejcts/ezab389 [DOI] [PubMed] [Google Scholar]
  53. van Le, D. , Jensen, G. V. H. , Carstensen, S. , & Kjøller‐Hansen, L. (2016). Cardiopulmonary exercise testing in patients with asymptomatic or equivocal symptomatic aortic stenosis: Feasibility, reproducibility, safety and information obtained on exercise physiology. Cardiology, 133(3), 147–156. 10.1159/000441292 [DOI] [PubMed] [Google Scholar]
  54. Zhang, Y. , Xu, L. , Yao, Y. , Guo, X. , Sun, Y. , Zhang, J. , & Fu, Q. (2016). Effect of short‐term exercise intervention on cardiovascular functions and quality of life of chronic heart failure patients: a meta‐analysis. Journal of Exercise Science & Fitness, 14(2), 67–75. 10.1016/j.jesf.2016.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Physiological Reports are provided here courtesy of Wiley

RESOURCES